Autoimmune lymphoproliferative syndrome primary prevention: Difference between revisions
No edit summary |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Autoimmune lymphoproliferative syndrome}} | {{Autoimmune lymphoproliferative syndrome}} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}}{{SharmiB}} | ||
==Overview== | ==Overview== | ||
| Line 15: | Line 13: | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Latest revision as of 04:16, 3 August 2021
|
Autoimmune lymphoproliferative syndrome Microchapters |
|
Differentiating Autoimmune lymphoproliferative syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Autoimmune lymphoproliferative syndrome primary prevention On the Web |
|
American Roentgen Ray Society Images of Autoimmune lymphoproliferative syndrome primary prevention |
|
FDA on Autoimmune lymphoproliferative syndrome primary prevention |
|
CDC on Autoimmune lymphoproliferative syndrome primary prevention |
|
Autoimmune lymphoproliferative syndrome primary prevention in the news |
|
Blogs on Autoimmune lymphoproliferative syndrome primary prevention |
|
Directions to Hospitals Treating Autoimmune lymphoproliferative syndrome |
|
Risk calculators and risk factors for Autoimmune lymphoproliferative syndrome primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sharmi Biswas, M.B.B.S
Overview
An autoimmune lymphoproliferative syndrome(ALPS) is a genetic disorder that is inherited in most cases. So, there are no primary prevention guidelines so far.
Primary Prevention
For the individuals with severe clinical phenotypes as ALPS-FAS which is caused by biallelic pathogenic variants, having severe refractory cytopenias developed lymphoma, or having complications from immunosuppressive therapy require bone marrow transplant which might be the only curative treatment.[1]